Cardiovascular risk of NSAIDs: time to translate knowledge into practice

PLoS Med. 2013;10(2):e1001389. doi: 10.1371/journal.pmed.1001389. Epub 2013 Feb 12.

Abstract

K. Srinath Reddy and Ambuj Roy discuss the Research Article by Patricia McGettigan and David Henry about the continued use of NSAIDs associated with increased risk of cardiovascular disease, including the mechanisms of increased risk, probable reasons for ongoing use, and next steps.

Publication types

  • Comment

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Anti-Inflammatory Agents, Non-Steroidal / economics*
  • Cardiovascular Diseases / chemically induced*
  • Commerce / economics*
  • Developed Countries / economics*
  • Developing Countries / economics*
  • Drug Costs*
  • Drug Industry / economics*
  • Drugs, Essential / adverse effects*
  • Drugs, Essential / economics*
  • Humans
  • Pharmacopoeias as Topic*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Drugs, Essential

Grants and funding

No specific funding was received by the authors to write this article.